Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
Jo‐Lewis Banga Ndzouboukou(Huazhong University of Science and Technology), Xionglin Fan(Huazhong University of Science and Technology), Qing Lei(Huazhong University of Science and Technology), Yandi Zhang(Liaoning Normal University), Leyong Yuan(Hubei University of Medicine), Xiaosong Lin(Huazhong University of Science and Technology), Hui Fu(Huazhong University of Science and Technology), Zongjie Yao(Huazhong University of Science and Technology)
Cited by 19
Related Papers
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
|Cell Reports|2021|184
CRISPR/Cas9-Based Mutagenesis of Starch Biosynthetic Genes in Sweet Potato (Ipomoea Batatas) for the Improvement of Starch Quality
|International Journal of Molecular Sciences|2019|147
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections
|Allergy|2020|138
Highly Specific Cys Fluorescence Probe for Living Mouse Brain Imaging via Evading Reaction with Other Biothiols
|Analytical Chemistry|2019|110